ANVISA registration 80146502433Valid until Aug 03, 2036HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY
ANVISA Registration Number: 80146502433ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT IRELAND DIAGNOSTICS DIVISIONRisk Class IV
Device names
- Technical name
- HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY
- Risk class
- Class IV
PT: ANTÍGENO E ANTICORPO DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA ADQUIRIDA TIPO 1 E TIPO 2 (HIV)
Registration details
- Registration Number
- 80146502433
- Process Number
- 25351033431202641
- CNPJ
- 56998701000116
Company information
- Registration Holder
- ABBOTT LABORATORIOS DO BRASIL LTDA
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturing Country
- Ireland
PT: IRLANDA
Dates and status
- Publication Date
- Aug 03, 2026
- Validity
- 03/08/2036
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV) ANTIGEN AND ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502433 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Aug 03, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.